HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao maintains a Buy rating on Evotec (NASDAQ:EVO) but lowers the price target from $11 to $8.
August 15, 2024 | 4:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Douglas Tsao maintains a Buy rating on Evotec but lowers the price target from $11 to $8.
The Buy rating suggests continued confidence in Evotec's long-term prospects, but the lowered price target indicates some short-term concerns or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100